Liposomes are a novel drug delivery system; they are bimolecular vesicle structures that form spontaneously when phospholipids are dispersed in water. Liposomes vary in size, composition and charge and serve as carriers for a wide range of drug molecules, such as chemotherapeutic agents, anti-microbial and viral drugs, anti-parasitic drugs, genetic material, vaccines, therapeutic proteins, anti-inflammatory drugs, hormones and natural drugs.
Liposomes are usually derived from natural products and are essentially non-toxic and biodegradable.
Liposomes themselves have the unique ability to preserve drug molecules inside their aqueous solution and in the lipid bilayer.
Selective drug delivery at the lesion site in vivo can increase the local concentration of the drug and enhance its pharmacological action.
Liposome-encapsulated drugs can significantly reduce the toxicity and side effects produced by the drug, as liposomes tend to avoid healthy organs and protect these organs from the effects of encapsulated drugs.
CD Formulation has extensive experience and knowledge in liposome technology and can provide a wide range of advice and solutions to our clients in conducting drug and drug delivery modality development, including liposome drug delivery system technology services, liposome formulation development services and modified liposome technology services.
CD Formulation provides solutions to enable pharmaceutical companies to deliver a wide range of drug molecules. We have proven liposome technology that provides stable drug molecule encapsulation and delivery efficiency to maximize the desired physiological effects and health benefits.
CD Formulation begins at the design stage by evaluating options for the use of liposome technology for the selected drug molecule. We will evaluate the most appropriate preparation process for you, then demonstrate one or more prototypes to you and proceed to examine long-term stability, manufacturing ramp-up and quality control.
After modifying liposomes to improve their performance and expand their applications, CD Formulation offers technical services for modified liposomes including:
CD Formulation provides you with products and services that meet the standards set by the market. We perform quality control at every step of the liposome technology development process and rigorous testing of the end result to ensure that our stringent quality standards are met. We are constantly developing and optimizing our liposome technology and can guarantee that the service you receive is of the highest quality.
CD Formulation provides integrated innovation solutions from strategy to implementation to help you increase opportunities and address challenges. Through our in-depth experience in many different industries, including consumer and technology, we bring innovative solutions and cross-industry best practices to drug development. If you have a requirement about our services, please contact us by phone or email, our colleagues will reply to you within three working days.